Literature DB >> 9802944

Penetrating anti-DNA monoclonal antibodies induce activation of human peripheral blood mononuclear cells.

D Portales-Pérez1, D Alarcón-Segovia, L Llorente, A Ruíz-Argüelles, C Abud-Mendoza, L Baranda, H de la Fuente, T Ternynck, R González-Amaro.   

Abstract

Different studies have shown that some autoantibodies are able to penetrate into living cells and that this phenomenon has functional consequences, including apoptosis. We have explored the effect of anti-DNA antibodies (Ab) on the in vitro activation of peripheral blood mononuclear cells (PBMNC) and found that a human polyclonal anti-DNA, IgG, which efficiently penetrated living cells, was able to induce the expression of different cell activation antigens in vitro such as CD69, CD71 or CD98 by PBMNC from normal individuals. However, the cell activation phenotype induced by anti-DNA Ab was considered anomalous since the expression of some activation antigens was not up-regulated, and others showed aberrant behaviour (such as down-regulation of ICAM-1 expression). Similar results were obtained using different murine anti-DNA monoclonal antibodies (mAb). In addition, mAb that showed an efficient ability to penetrate living cells tended to have a greater effect on PBMNC activation. Anti-DNA Ab were also able to induce a noticeable expression of CD95/Fas. These data indicate that penetrating anti-DNA Ab are able to induce an anomalous activation state in vitro in a significant fraction of PBMNC. We believe this effect may occur in vivoand could have an important function in the pathogenesis of the immune dysregulation seen in SLE. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802944     DOI: 10.1006/jaut.1998.0218

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  10 in total

1.  Caspase-dependent cytotoxicity of anti-DNA autoantibodies.

Authors:  L P Sashchenko; S V Khaidukov; A V Kozyr; T I Luk'yanova; A G Gabibov; S V Suchkov; T V Bobik; Z S Alekberova; N V Gnuchev
Journal:  Dokl Biochem Biophys       Date:  2001 Sep-Oct       Impact factor: 0.788

2.  Immunophenotypic characterization of lymphoid cell infiltrates in vitiligo.

Authors:  S Sanchez-Sosa; M Aguirre-Lombardo; G Jimenez-Brito; A Ruiz-Argüelles
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

3.  Nuclear-targeting autoantibodies induced nuclear PARP cleavage accompanied by more pronounced decrease of peripheral white blood cells than Ro/SSA and La/SSB antigen-targeting autoantibodies.

Authors:  Ingrid Böhm
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

4.  IgG deposits can be detected in cell nuclei of patients with both lupus erythematosus and malignancy.

Authors:  Ingrid Böhm
Journal:  Clin Rheumatol       Date:  2007-03-16       Impact factor: 2.980

5.  Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE.

Authors:  Mirjana Pavlovic; Anna Kats; Michelle Cavallo; Ran Chen; James X Hartmann; Yehuda Shoenfeld
Journal:  Autoimmune Dis       Date:  2010-07-20

6.  Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice.

Authors:  Ke Guo; Jing Ping Tang; Li Jie; Abdul Qader O Al-Aidaroos; Cheng William Hong; Cheng Peow Bobby Tan; Jung Eun Park; Leyon Varghese; Zhiwei Feng; Jianbiao Zhou; Wee Joo Chng; Qi Zeng
Journal:  Oncotarget       Date:  2012-02

7.  Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin.

Authors:  Aggeliki D Sali; Ioannis Karakasiliotis; Maria Evangelidou; Stratis Avrameas; Peggy Lymberi
Journal:  Clin Transl Immunology       Date:  2015-10-02

8.  A Novel Method for Real-Time, Continuous, Fluorescence-Based Analysis of Anti-DNA Abzyme Activity in Systemic Lupus.

Authors:  Michelle F Cavallo; Anna M Kats; Ran Chen; James X Hartmann; Mirjana Pavlovic
Journal:  Autoimmune Dis       Date:  2012-12-05

9.  Peptide Sharing Between Viruses and DLX Proteins: A Potential Cross-Reactivity Pathway to Neuropsychiatric Disorders.

Authors:  Guglielmo Lucchese; Benjamin Stahl
Journal:  Front Neurosci       Date:  2018-03-21       Impact factor: 4.677

10.  Anti-β2 -glycoprotein I antibody with DNA binding activity enters living monocytes via cell surface DNA and induces tissue factor expression.

Authors:  S Virachith; M Saito; Y Watanabe; K Inoue; O Hoshi; T Kubota
Journal:  Clin Exp Immunol       Date:  2018-11-28       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.